miR-18a directly targets ER-alpha and this miRNA is highly expressed in ER-alpha-negative tumors as compared to ER-alpha-positive tumors, thus providing the first direct evidence of miRNAs inhibiting ER-alpha signaling in BC [25]. The gene discussed is ESR1; the disease is breast cancer.